Literature DB >> 3917885

Use of the BACTEC system for drug susceptibility testing of Mycobacterium tuberculosis, M. kansasii, and M. avium complex.

J E Steadham, S K Stall, J L Simmank.   

Abstract

A total of 199 Mycobacterium tuberculosis, 182 M. kansasii, and 32 M. avium complex isolates were tested for susceptibility to either three or 10 color-coded drugs in a four-phase study using the conventional 7H10 plate method and the BACTEC system. Agreement between the two test systems for M. tuberculosis isolates against isoniazid, ethambutol, and rifampin was 96%; it was 93.6% against all 10 drugs. Disagreement was highest for ethionamide and cycloserine. M. kansasii data were encouraging, with 88.9% drug agreement against 10 drugs, but M. avium complex agreement was only 51.6% against 10. Average time required for reportable results was 4.8 days for M. tuberculosis, 4.3 days for M. kansasii, and 3.4 days for M. avium complex. Growth for 3 days in an enrichment medium yielded suspensions of the organisms in a logarithmic growth phase and reduced problems of clumps of cells in inocula.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3917885     DOI: 10.1016/0732-8893(85)90064-1

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  7 in total

Review 1.  Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.

Authors:  Barbara A Brown-Elliott; Kevin A Nash; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

2.  In vitro activities of several new macrolide antibiotics against Mycobacterium avium complex.

Authors:  S Naik; R Ruck
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

3.  Susceptibility testing of slowly growing mycobacteria by a microdilution MIC method with 7H9 broth.

Authors:  R J Wallace; D R Nash; L C Steele; V Steingrube
Journal:  J Clin Microbiol       Date:  1986-12       Impact factor: 5.948

4.  Synergistic effects of antimycobacterial drug combinations on Mycobacterium avium complex determined radiometrically in liquid medium.

Authors:  S E Hoffner; S B Svenson; G Källenius
Journal:  Eur J Clin Microbiol       Date:  1987-10       Impact factor: 3.267

5.  Comparative in vitro activities of linezolid, telithromycin, clarithromycin, levofloxacin, moxifloxacin, and four conventional antimycobacterial drugs against Mycobacterium kansasii.

Authors:  Fernando Alcaide; Laura Calatayud; Miguel Santín; Rogelio Martín
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

6.  The interval between initiation of anti-tuberculosis treatment in patients with culture-positive pulmonary tuberculosis and receipt of drug-susceptibility test results.

Authors:  Joon-Sung Joh; Chang Hoon Lee; Ji Eun Lee; Young-Kil Park; Gill-Han Bai; Eui-Chong Kim; Sung Koo Han; Young-Soo Shim; Jae-Joon Yim
Journal:  J Korean Med Sci       Date:  2007-02       Impact factor: 2.153

7.  In-vitro antimycobacterial drug susceptibility testing of non-tubercular mycobacteria by tetrazolium microplate assay.

Authors:  Manimuthu Mani Sankar; Krishnamoorthy Gopinath; Roopak Singla; Sarman Singh
Journal:  Ann Clin Microbiol Antimicrob       Date:  2008-07-11       Impact factor: 3.944

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.